Next Article in Journal
Mechanisms of Alpha-Synuclein Action on Neurotransmission: Cell-Autonomous and Non-Cell Autonomous Role
Next Article in Special Issue
A Perspective on the Enhancer Dependent Bacterial RNA Polymerase
Previous Article in Journal
Oxidative Stress and the Homeodynamics of Iron Metabolism
Previous Article in Special Issue
Base Flipping in Open Complex Formation at Bacterial Promoters
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 5
Issue 2
10.3390/biom5020848
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Structural Biology of Bacterial RNA Polymerase

by
Katsuhiko S. Murakami
Department of Biochemistry and Molecular Biology, The Center for RNA Molecular Biology, The Pennsylvania State University, University Park, PA 16802, USA
Biomolecules 2015, 5(2), 848-864; https://doi.org/10.3390/biom5020848
Submission received: 9 March 2015 / Revised: 10 April 2015 / Accepted: 13 April 2015 / Published: 11 May 2015
(This article belongs to the Special Issue Bacterial RNA Polymerase)
Browse Figures
Versions Notes

Abstract

:
Since its discovery and characterization in the early 1960s (Hurwitz, J. The discovery of RNA polymerase. J. Biol. Chem. 2005, 280, 42477–42485), an enormous amount of biochemical, biophysical and genetic data has been collected on bacterial RNA polymerase (RNAP). In the late 1990s, structural information pertaining to bacterial RNAP has emerged that provided unprecedented insights into the function and mechanism of RNA transcription. In this review, I list all structures related to bacterial RNAP (as determined by X-ray crystallography and NMR methods available from the Protein Data Bank), describe their contributions to bacterial transcription research and discuss the role that small molecules play in inhibiting bacterial RNA transcription.

1. Early Research on the Structure of Bacterial RNA Polymerase

The common core of multi-subunit RNAP in cellular organisms is composed of five subunits that are conserved in all three domains of life. Bacterial RNAP core enzyme is the simplest and best characterized form, consisting of α (two copies), β, β', and ω subunits (Figure 1 and Figure 2a). The core enzyme is responsible for binding to template DNA to synthesize RNA, which is complemented by a σ factor to form a holoenzyme that recognizes the promoter sequence to begin promoter-specific transcription [1,2].
Biomolecules 05 00848 g001 1024
Figure 1. RNAP assembly and transcription cycle. The figure shows the general scheme for bacterial RNAP assembly and the transcription cycle. PDB codes of RNAP structures (in brackets) belonging to each phase of the transcription cycle.
Figure 1. RNAP assembly and transcription cycle. The figure shows the general scheme for bacterial RNAP assembly and the transcription cycle. PDB codes of RNAP structures (in brackets) belonging to each phase of the transcription cycle.
Biomolecules 05 00848 g001
Structural study of bacterial RNAP by electron microscopy [3] began in the mid-1960s. Crystallization of RNAP isolated from Thermusthermophilus was first reported in the late 1970s [4]; however, the X-ray crystal structure was not determined until the end of the millennium. Before determining the complete structure of RNAP, stable domains and subcomplexes within RNAP were targeted for structural studies (Table 1). These structures were important guides for building the entire structure of RNAP.
The first atomic view of RNAP was obtained from the C-terminal domain of Escherichia coli RNAP α subunit (residues 250–329), also known as αCTD (PDB: 1COO) [5], which plays important roles in regulating transcription via interaction with many transcription factors (Figure 2a) and also binds to the upstream promoter DNA [6]. The structure of αCTD was determined by NMR, which revealed its compact structure and distinct protein topology compared with other DNA binding proteins. The characterization of the structure of αCTD was a springboard for a series of mutagenesis experiments that revealed communication of bacterial RNAP with numerous transcription factors during gene regulation.
Biomolecules 05 00848 g002 1024
Figure 2. (a) Three-dimensional representation of the interaction between RNAP and transcription factors. The E. coli RNAP holoenzyme is shown as a molecular surface representation (α subunits: white; β subunit: cyan; β’ subunit: pink; ω subunit: gray; σ70: orange; σ region 1.1: red). Transcription factors binding sites are indicated in double quotation marks and PDB codes of structures are shown in brackets; (b) Three-dimensional representation of the interaction between σ and anti-σ factors. E. coli RNAP holoenzyme is shown as a molecular surface representation, and only the core enzyme is partially transparent (α subunits: white; β subunit: cyan; β’ subunit: pink; ω subunit: gray; σ70: orange). Targets of anti-σ factors are indicated in double quotation marks and PDB codes of structures are shown in brackets.
Figure 2. (a) Three-dimensional representation of the interaction between RNAP and transcription factors. The E. coli RNAP holoenzyme is shown as a molecular surface representation (α subunits: white; β subunit: cyan; β’ subunit: pink; ω subunit: gray; σ70: orange; σ region 1.1: red). Transcription factors binding sites are indicated in double quotation marks and PDB codes of structures are shown in brackets; (b) Three-dimensional representation of the interaction between σ and anti-σ factors. E. coli RNAP holoenzyme is shown as a molecular surface representation, and only the core enzyme is partially transparent (α subunits: white; β subunit: cyan; β’ subunit: pink; ω subunit: gray; σ70: orange). Targets of anti-σ factors are indicated in double quotation marks and PDB codes of structures are shown in brackets.
Biomolecules 05 00848 g002
Table
Table 1. Structural information on bacterial RNAP.
Table 1. Structural information on bacterial RNAP.
StructurePDB codeReferenceSource
Subunit and domain
α subunit NTD1BDFX[7]A
α subunit NTD4NOIXnoneF
α subunit CTD1COON, 3K4GX[5,8]A
α subunit CTD1DOQN[9]B
α subunit CTD2MAXN[10]E
β subunit 2/i4 domains3LTIX[11]A
β subunit flap domain2LY7NnoneC
β subunit 1/2 domains4KBJX[12]I
β' subunit i2 domain2AUJX[13]B
β' subunit i6 domain2AUKX, 4IQZX[13]A
σ region 1.12K6XN[14]G, a
σ70 domain21SIGX[15]A, a
σA domains2 and 31KU2X[16]B, a
σA domain41KU3X[16]B, a
σA domain4–DNA (−35 element)1KU7X[16]B, a
σA domain41TTYN[17]G, a
σA domain2–DNA (−10 element)3UGOX, 3UGPX[18]B, a
σA domain4–αCTD–DNA3N97XnoneB, a, A
σNRpoN–DNA (−24 element)2O8KN, 2O9LN[19]D, d
σN core binding domain2K9MN[20]D, d
σNRpoN domain2AHQN[21]D, d
σEdomain4–DNA (−35 element)2H27X[22]A, c
σC domain22O7GX[23]I, c
σC domain42O8XX[23]I, c
σD domain43VFZX[24]I, c
δ subunit NTD2KRCN, 4NC7X, 4NC8X, 2M4KN, 2KRCN[25,26,27]C
ε subunit4NJCX[28]C
RNAP
Core enzyme1HQMX[29,30]B
Core enzyme (Δω subunit)2GHOX[31]B
Holoenzyme1L9UX, 1IW7X, 2A6EX, 2CW0X[32,33,34]B
Holoenzyme4YG2X, 4LJZX, 4MEYX[35,36,37]A
Holoenzyme–DNA (−41 ~ −7) 1L9ZX[38]B
Holoenzyme–DNA (−12 ~ +12) 4G7HX, 4G7OX[39]B
de novo initiation complex4Q4ZX, 4OIOX[40,41]B
Initially transcribing complex4Q5SX[40]B
Elongation complex2O5IX, 2O5JX[42,43]B
Paused elongation complex4GZYX, 4GZZX[44]B
Backtracked elongation complex4WQSX[45]B
A: Escherichia coli; B: Thermus aquatics/Thermus thermophilus; C: Bacillus subtilis/Bacilus stearothermophilus; D: Aquifex aeolicus; E: Helicobacter pylori; F: Campylobacter jejuni; G: Thermotoga maritime; I: Mycobacterium tuberculosis; a: group I σ factor; c: extracytoplasmic function (ECF) σ factor; d: σN/σ54 factor; X: X-ray crystallography method; N: NMR method.
A subsequent study revealed the X-ray crystal structure of the α subunit N-terminal domain (αNTD) (PDB: 1BDF) [7]. The structure showed the α subunit homodimer, which is an essential platform for binding of the largest subunits, β and β' (Figure 1).
β and β' subunits form the catalytic center of RNA synthesis and also provide binding sites for double-stranded downstream DNA, DNA/RNA hybrid formed during transcription and RNA. These subunits are highly conserved in bacteria; however, large sequence insertions found in these subunits characterize specific evolutionary lineages of bacteria. These insertions can be isolated as stable domains and crystallized for determining X-ray structures (Table 1). These structures have contributed to providing atomic images of bacterial RNAP because these lineage-specific insertions are located on the peripheral surface of RNAP and electron density maps of these domains are of relatively poor quality in the bacterial RNAP crystals.
σ factor transiently associates with the core enzyme for promoter recognition and it dissociates from the core enzyme once RNAP starts processive RNA synthesis (Figure 1). Proteolysis of σ factor determines its domain organization and structures of some stable domains have been determined by X-ray crystallography and NMR (Table 1). In 1996, the first image of σ factor was obtained from the E. coli group I σ70 (also known as σD) N-terminal domain containing regions 1.2–2.4 (PDB: 1SIG) [15], which provided insight into the recognition of a −10 element and melting of the promoter DNA by the σ regions 2.4 and 2.3, respectively. A nearly complete view of σ factor was obtained from two proteolytic fragments of Thermus aquaticus σA. One fragment contained σ domain 2 (σ2: region 1.2–2.4) and σ domain 3 (σ3: region 3.0–3.1) (PDB: 1KU2), while another fragment contained σ domain 4 (σ4: region 4.1–4.2) (PDB: 1KU3) [16].

2. An Explosion of Structural Information on Bacterial RNA Polymerase

The entire structure of bacterial RNAP was first described as a core enzyme form and was isolated from the thermophilic bacterium T. aquaticus (PDB: 1HQM) [29]. This was an important milestone in the study of bacterial transcription that provided a structural framework for four decades of bacterial transcription research. The structure revealed a unique crab claw-shaped molecule, which was distinct from the T7 phage-like single-subunit RNAP family composed of right-hand-shaped molecules. The configuration of the bacterial RNAP active site was also different from that of the single-subunit RNAP [46], even though these enzymes use the same two-metal ion mechanism [47] for RNA synthesis. Comparison of cellular RNAPs from three domains of life, including eukaryotic RNAPs I [48,49] and II [50] as well as archaeal RNAP [51], revealed a conserved overall shape with multi-subunit arrangement and an active site cleft with conserved motifs including a bridge helix (separating the main and secondary channels), trigger loop (for RNA synthesis and cleavage) and switches (for accommodating DNA and RNA into the RNAP clefts).

3. Structural Basis of Transcription Elongation

Crystals of the transcription elongation complex were prepared using T. thermophilus RNAP and a synthetic DNA/RNA scaffold, and structures were determined with and without a nucleotide triphosphate substrate (PDB: 2O5I, 2O5J) [42,43]. Structures revealed atomic details of RNAP and DNA/RNA interactions within the DNA binding main channel and the RNA exit channel and showed how the RNAP mobile element trigger loop changes conformation throughout nucleotide substrate selection and phosphodiester bond formation.
During RNA extension, RNAP temporarily stops transcription (transcription pausing) by several mechanisms including σ factor-dependent promoter proximal pausing, elemental pausing, RNA hairpin-dependent pausing and backtrack pausing (Figure 1) [52]. The structure of an elemental-paused elongation complex using Thermus RNAP and DNA/RNA scaffolds derived from the E. coli his-pause sequence showed a unique RNAP conformation including an open-clamp and kinked bridge helix that may inhibit processive RNA extension (PDB: 4GZY, 4GZZ) [44].
Misincorporated nucleotides in RNA transcripts slow down the rate of transcription and result in the backward movement of RNAP (backtracking), which ejects the 3' RNA end into the secondary channel and later cleaves misincorporated nucleotides by RNAP endonuclease activity (Figure 1). This activity is further stimulated by the elongation factor GreA. The structure of this single-nucleotide-backtracked elongation complex showed a sharply bent RNA backbone at the unpaired RNA base, which accommodated the proofreading cavity of the RNAP active site (PDB: 4WQS) [45]. This study also revealed the structure of RNAP in complex with GreA-like protein, showing that the GreA coiled-coil domain containing acidic residues binds to the RNAP active site through the secondary channel and coordinates Mg2+, which is essential for RNA cleavage (PDB: 4WQT).
The transcription factor RapA is an ATP-dependent DNA translocase, which reactivates the stalled elongation complex (Figure 1). The structure of the elongation complex with RapA showed that RapA binds around the RNA exit site, making the RNA channel just wide enough for single-stranded RNA to pass (PDB: 4S20) [53].

4. Promoter-Dependent Transcription: How RNA Polymerase Recognizes Promoter DNA Sequences and Initiates Transcription

Bacterial RNAP recognizes promoter DNA and initiates transcription as the holoenzyme form containing the catalytic core enzyme plus the promoter recognition σ factor (Figure 1). Structures of the holoenzyme containing the group I σ factor σA (also known as SigA), isolated from T. aquaticus and T. thermophilus, showed that three σ domains (σ domains 2, 3, and 4) arranged on the surface of the core enzyme whose function was to recognize the −35 and−10 elements (separated by ~17 bp DNA) (PDB: 1L9U, 1IW7) [32,33] (Table 1). The structure of the holoenzyme in complex with fork junction promoter DNA (−41 to −7 relative to the transcription start site at +1) showed that the promoter DNA lies across one face of the holoenzyme and is positioned completely outside the RNAP cleft (PDB: 1L9Z) [38]. Universally conserved aromatic residues in the σ region 2.3 are ideally positioned to stack on the exposed face of the base pair at the upstream edge of the transcription bubble.
Atomic details of −35 element recognition by σ domain 4 (σ4), as revealed by co-crystal structure, showed that the helix-turn-helix motif of σ4 reads the hexameric DNA sequence (PDB: 1KU7) [16]. Details of the interaction between σ2 and the −10 element were obtained from the structure of σ2 bound to the single-stranded −10 element (PDB: 3UGO, 3UGP) [18] and the T. thermophilus RNAP holoenzyme in complex with the promoter DNA fragment (−12 to +12 on DNA) (PDB: 4G7H, 4G7O) [39]. The holoenzyme/DNA complex structure also showed interactions between σ region 3.2 and template DNA, as well as the presence of core enzyme and non-template DNA in the transcription bubble in order to position the transcription start site of the template DNA at the RNAP active center for initiation of transcription.
Cellular RNAPs start transcription by de novo RNA priming (Figure 1). Structures of the T. themophilus de novo transcription initiation complex revealed unique contact by the initiating NTPs bound at the transcription start site with template DNA and with RNAP (PDB: 4Q4Z, 4OIO) [40,41]. The RNAP promoter DNA complex was active in the crystalline state and capable of transcribing RNA to 6-mer lengths, allowing to determine the structure of the initial transcription complex (PDB: 4Q5S) [40]. The structure showed that RNAP-RNA contacts stabilized the short RNA transcript in the active site cleft and that the RNA 5' end displaced the σ finger from its position near the active site, which was suggested as a first step in σ release from the RNAP.

5. Structures of Alternative σ Factors

Bacterial RNAP uses a group I σ factor (σ70 in E. coli and σA in other bacteria) for transcribing housekeeping genes required for log-phase growth. Other classes of σ factors, including the group 2 σ factors (σS, σH, and σF in E. coli), the extracytoplasmic function (ECF) σ factors (σE and FecI in E. coli), and σN (also known as σ54), direct RNAP to genes for induction of stress responses, flagella synthesis, and spore formation in spore-forming bacteria, such as Bacillus. Structures of these alternative σ factors were determined as stable domains (Table 1) and provided insights into the mechanism of promoter DNA recognition. Structures of some alternative σ factors have been determined as σ/anti-σ factor complexes, and these structures will be described below (Table 2 and Figure 2b). To date, there has been no high-resolution structure that supports bacterial holoenzyme having any alternative σ factor.
Table
Table 2. Structural information on bacterial RNAP and transcription factor complexes.
Table 2. Structural information on bacterial RNAP and transcription factor complexes.
StructurePDBReferencesSource
σ/anti-σ complex
σF domains2, 3, 4/FlgM1SC5X, 1RP3X[54]D, b
σE domains2, 4/ChrR2Z2SX, 2Q1ZX[55]J, c
σE domains2, 4/RseA1OR7X[56]A, c
σK domains2, 4/RskA4NQWX[57]I, c
σF domain3/SpoIIAB1L0OX[58]C, b
σ70 domain4/Rsd2P7VX[59]A, a
σD domain4/RsdA3VEPX[24]I, c
σL domain4/RslA3HUGX[60]I, c
Transcription factor complex
αCTD–CAP–DNA1LB2X, 3N4MX[61]A
αCTD–Spx1Z3EX, 3GFKX, 3IHQX[62,63,64]C
αCTD–NusA (AR2)2JZBNnoneH, A
β subunit 1/2 domains–CarD4KBMX[12]I
β subunit 1 domain–TRCF3MLQX[65]B
σA domain4–λcI–DNA1RIOX[66]B
σ70 domain4–PhoB–β flap–DNA3T72X[67]A
Holoenzyme–CAP–DNA3IYDC[68]A
Core enzyme–GreA/Gfh14WQTX[45]B
Elongation complex–Gfh13AOHX, 3AOIX[69]B
Elongation complex –RapA4S20X[53]A
Phage factor complex
Holoenzyme–gp24LK0X, 4LLGX[36]A
β' subunit jaw domain–gp22LMCN[70]A
β subunit flap domain–gp333TBIX[71]A
Holoenzyme–gp393WODX[72]B
β subunit flap domain –gp393WOFX, 3WOEX[72]B
σ70 domain4–AsiA1TLHN[17]A, a
σA domain4–gp674G8XX[73]K, a
A: Escherichia coli; B: Thermus aquatics/Thermus thermophilus; C: Bacillus subtilis/Bacilus stearothermophilus; D: Aquifex aeolicus; H: Yersinia pseudotuberculosis; I: Mycobacterium tuberculosis; K: Staphyloccus aureus; a: group I σ factor; b: group II σ factor; c: extracytoplasmic function (ECF) σ factor; X: X-ray crystallography method; C: Cryo-EM single-particle analysis method; N: NMR method.

6. A New Era of Structural Study of Bacterial Transcription Using E. coli RNA Polymerase

Crystal structures of bacterial RNAPs have been determined using the Thermus genus. Due to a high degree of RNAP sequence conservation among all bacterial species, mechanistic insight derived from the Thermus RNAP structure has been generalized to represent the transcription apparatus in all bacteria. Nevertheless, understanding the structure of E. coli RNAP is essential to fully interpret the enormous amount of biochemical, biophysical, and genetic data that has been collected on E. coli RNAP. In 2013, the first crystal structure of the E. coli RNAP σ70 holoenzyme was determined (PDB: 4YG2) [35]. E. coli RNAP can be readily prepared using an overexpression system, which allows RNAP structural study to move in a new direction using RNAP mutants.
Characterization of E. coli RNAP has created new possibilities for the structural study of bacterial RNAP. Sixteen structures of E. coli RNAP with transcription factors or small molecules have been determined already, including the long-awaited structure of E. coli RNAP in complex with (p)ppGpp, a master regulator of stress response in bacteria (PDB: 4JK1, 4JK2, 4JKR) [74,75] (Table 3 and Figure 3). The ppGpp binding site of T. thermphilus RNAP was also determined from the crystal structure of the T. thermphilus RNAP–ppGpp complex (PDB: 1SMY) [76], but it failed to verify its relevance to E. coli transcription regulation by ppGpp [77].

7. Transcription Regulation: How RNA Polymerase Communicates with Transcription Factors

Binding of alternative σ factors to the RNAP core enzyme is regulated by anti-σ factor, which forms a stable complex with its target σ factor and blocks core RNAP binding. Structures of the σ/anti-σ factor complex have shown various ways that the core enzyme-binding interface of σ factor can be masked (Table 2 and Figure 2b). The σ/anti-σ complex has also contributed to providing high-resolution images of σ factor, since σ factor is notorious for having a heterogenous conformation and is difficult to crystallize in isolation.
Bacterial RNAP physically interacts with protein factors during gene regulation. Most bacterial transcription factors bind upstream of promoter DNA and recruit RNAP to target promoters and/or facilitate formation of the open complex. Three crystal structures of a transcription factor, RNAP domain, and DNA ternary complex have provided insights into how these factors influence transcription activation through different mechanisms (Table 2 and Figure 2a).
Catabolite activator protein (CAP) (also known as cAMP receptor protein CRP) is the most well characterized bacterial transcription factor, providing insights into the interaction between the helix-turn-helix motif and DNA, the allosteric control of DNA binding, and transcription activation. In classical lactose operon regulation [78], CAP binds DNA ~60 bp upstream from the transcription start site (class I transcription factor binding site) and interacts with αCTD [6,79]. The crystal structure of the CAP–αCTD–DNA ternary complex provided a first view of the transcription factor–RNAP interaction as well as the αCTD–DNA interaction (PDB: 1LB2) [61]. The structure showed that these proteins interact with small interfaces, but it is sufficient for RNAP to target the promoter. A low-resolution view of the transcription initiation complex including E. coli RNAP, CAP, and promoter DNA has been determined by cryo-electron microscopy (EMD ID, EMD-5127; PDB: 3IYD) [68].
Bacteriophage λ cI protein (λcI) plays a central role in the lytic to lysogenic growth switch and is able to both activate and repress transcription. For activation of transcription, λcI binds just upstream of the −35 element (class II transcription factor binding site) and interacts with σ domain 4 (σ4). The crystal structure of the λcI–σ4–DNA ternary complex showed that these proteins also use a small interface for recruiting σ4 to the −35 element (PDB:1RIO) [66].
PhoB is a classical two-component response regulator, which interacts with σ4 to activate gene expression. In contrast with λcI-dependent transcription activation, PhoB-dependent promoters lack a canonical −35 element. The structure of the PhoB–σ4–DNA ternary complex showed that contact between σ4 and the DNA major groove is less extensive; however, interaction between σ4 and PhoB compensates for this, allowing recruitment of RNAP to a target promoter lacking the −35 element (PDB: 3T72) [67].
Spx is a global transcription regulator in Bacillus subtilis that interacts with a large interface on αCTD, thereby forming a stable Spx–αCTD complex without a DNA platform. Spx regulates gene expression under conditions of disulfide stress, which is sensed by disulfide bond formation between two cysteine residues in Spx. Crystal structures of both oxidized and reduced forms of the Spx–αCTD complex provided insight into how the disulfide bond affects DNA binding (PDB: 1Z3E, 3GFK, 3IHQ) [62,63,64].
Bacteriophages produce transcription factors that bind directly with host RNAPs and hijack host transcription machinery to transcribe phage genomes. Several structural models of bacterial RNAP in complex with phage proteins have been used to explain how phage protein remodels RNAP to redirect transcription machinery to the phage genome (Table 2 and Figure 2a) [17,36,70,71,72,73].

8. How Small Molecules Inhibit RNA Transcription

Bacterial RNAP is essential for cell growth and viability, and lack of sequence and structural similarities between certain areas of bacterial and eukaryotic RNAP make this enzyme an attractive target for antibiotic development. Crystal structures of bacterial RNAP in complex with small molecule transcription inhibitors have been used to characterize binding sites, mechanisms of action, and mechanisms of resistance (Table 3 and Figure 3). Currently, two bacterial RNAP inhibitors, rifampin (also known as rifampicin) and fidaxomicin (also known as DIFICID® and lipiarmycin), have been used in clinical practice. Rifampin, a semisynthetic rifamycin, is the cornerstone of current tuberculosis treatment. Structures of the RNAP–rifampin complex (T. aquaticus core enzyme, PDB: 1YNN; E. coli holoenzyme, PDB: 4KMU) provided a detailed view of the interaction between rifampin and the β subunit and explained how rifampin blocks RNA extension [80,81]. The rifampin binding site is also recognized by sorangicin, which prevents extension of short RNA (PDB: 1YNJ) [82]. Chemical modifications of rifampin have provided an additional RNAP-drug interface that may enhance drug affinity and efficacy, as well as reduce the frequency of spontaneous resistance mutations. Structures of RNAP holoenzymes in complex with rifampin derivatives (T. thermophiles holoenzyme, PDB: 2A68, 2A69; E. coli holoenzyme, PDB: 4KN4, 4KN7) showed an additional interaction with the σ region 3.2 (σ finger) that may influence binding of template DNA at the active site, thereby reducing the efficiency of transcription initiation [81,83]. The structure of RNAP in complex with GE23077 (PDB: 4MQ9, 4OIN, 4OIP), a drug that inhibits nucleotide binding, provided a framework for creating a bipartite compound by tethering rifampin with GE23077, which has superior affinities for both rifampin-susceptible and rifampin-resistant RNAPs (PDB: 4OIR) [41].
Table
Table 3. Structural information on bacterial RNAP and small molecule inhibitor complexes *.
Table 3. Structural information on bacterial RNAP and small molecule inhibitor complexes *.
StructurePDBReferenceSource
Core enzyme–rifampin1YNN[80]B
Holoenzyme–rifampin4KMU[81]A
Holoenzyme–rifampin derivatives2A68, 2A69[83]B
Holoenzyme–rifampin derivatives4KN4, 4KN7[81]A
Holoenzyme–ppGpp1SMY[76]B
Holoenzyme–ppGpp4JK1, 4JKR[74,75]A
Holoenzyme–pppGpp4JK2[74]A
Core enzyme–sorangicin1YNJ[82]B
Holoenzyme–streptolydigin1ZYR, 2A6H[34,84]B
Elongation complex–streptolydigin2PPB[42]B
Holoenzyme–myxopyronin3DXJ, 3EQL[85,86]B
Holoenzyme–myxopyronin4YFX[87]A
Holoenzyme–GE230774MQ9[41]B
Holoenzyme–DNA–GE230774OIN, 4OIP[41]B
Holoenzyme–DNA–GE23077/rifamycin SV4OIR[41]B
Holoenzyme–salinamide A4MEX[37]A
Holoenzyme–squaramide4YFK, 4YFN[87]A
A: Escherichia coli; B: Thermus aquatics/Thermusthermophilus; * All structures in this table were determined by X-ray crystallography method.
Streptolydigin binds to key elements of the RNAP active site (bridge helix and trigger loop) and inhibits all reactions involved in RNAP transcription by blocking conformational changes in these elements that occur during transcription. Structures of the RNAP–streptolydigin complex revealed that it traps the bridge helix and trigger loop in straight and unfolded conformational states, respectively, by direct interaction with these elements (PDB: 2PPB, 1ZYR, 2A6H) [34,42,84].
Myxopyronin binds to the RNAP switch region, which is a hinge of the RNAP clamp whose function is to open and close the DNA-binding channel. Upon binding, myxopyronin inhibits transcript initiation by preventing formation of the promoter open complex. Structural and biochemical studies on the T. thermophilus RNAP–myxopyronin complex (PDB: 3DXJ, 3EQL) have proposed two models of inhibition: myxopyronin inhibits transcription (1) by preventing the opening of the RNAP clamp that permits entry and unwinding of DNA (hinge jamming mechanism) [85] or (2) by interfering with interactions between RNAP and the unwound DNA template strand [86].
Biomolecules 05 00848 g003 1024
Figure 3. Three-dimensional representation of targets of small-molecule RNAP inhibitors. E. coli RNAP holoenzyme is depicted as an α-carbon backbone traced with partially transparent molecular surfaces (α subunits: white; β subunit: cyan; β' subunit: pink; ω subunit: gray; σ70: orange). Small-molecule inhibitors bound to RNAP are depicted as CPK models. Chemical structures of small-molecule inhibitors and mechanisms of transcription inhibition are indicated.
Figure 3. Three-dimensional representation of targets of small-molecule RNAP inhibitors. E. coli RNAP holoenzyme is depicted as an α-carbon backbone traced with partially transparent molecular surfaces (α subunits: white; β subunit: cyan; β' subunit: pink; ω subunit: gray; σ70: orange). Small-molecule inhibitors bound to RNAP are depicted as CPK models. Chemical structures of small-molecule inhibitors and mechanisms of transcription inhibition are indicated.
Biomolecules 05 00848 g003
A new structure of a bacterial RNAP–inhibitor complex was obtained by using salinamide, which binds the N-terminal end of the bridge helix and prevents nucleotide addition (PDB: 4MEX) [37]. Squaramide is a non-natural bacterial RNAP inhibitor isolated by high-throughput screening, and its binding site was predicted at the switch region, based on analysis of squaramide-resistant RNAP mutants followed by computational modeling using the structure of the T. thermophilus RNAP–myxopyronin complex [88]. Crystal structures of E. coli RNAP in complex with squaramides were determined, structurally confirming that squaramides bind to RNAP switches (PDB: 4YFK, 4YFN) [87].
During the past decade, our understanding of bacterial transcription processes has drastically improvedas a result of structural studies on bacterial RNAP. I hope this review will be a useful reference for researchers who study the mechanism, structure and function of bacterial RNAP transcription and that structures presented in this review will provide guidelines for designing new experiments.

Acknowledgements

This work was supported by NIH grant GM087350. Figures were prepared using PyMOL. The author dedicates this work to the memory of Yoshimasa Kyogoku.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Murakami, K.S.; Darst, S.A. Bacterial RNA polymerases: The wholo story. Curr. Opin. Struct. Biol. 2003, 13, 31–39. [Google Scholar] [CrossRef] [PubMed]
  2. Jun, S.H.; Warner, B.A.; Murakami, K.S. RNA polymerase reaction in bacteria. In Encyclopedia of Biological Chemistry; Lane, W.J.L.D., Ed.; Academic Press: Waltham, MA, USA, 2013; pp. 167–172. [Google Scholar]
  3. Fuchs, E.; Zillig, W.; Hofschneider, P.H.; Preuss, A. Preparation and properties of RNA-polymerase particles. J. Mol. Biol. 1964, 10, 546–550. [Google Scholar] [CrossRef] [PubMed]
  4. Tsuji, S.; Suzuki, K.; Imahori, K. Crystallisation of DNA-dependent RNA polymerase from Thermus thermophilus HB 8. Nature 1976, 261, 725–726. [Google Scholar] [CrossRef] [PubMed]
  5. Jeon, Y.H.; Negishi, T.; Shirakawa, M.; Yamazaki, T.; Fujita, N.; Ishihama, A.; Kyogoku, Y. Solution structure of the activator contact domain of the RNA polymerase alpha subunit. Science 1995, 270, 1495–1497. [Google Scholar] [CrossRef] [PubMed]
  6. Ishihama, A. Role of the RNA polymerase alpha subunit in transcription activation. Mol. Microbiol. 1992, 6, 3283–3288. [Google Scholar] [CrossRef] [PubMed]
  7. Zhang, G.; Darst, S.A. Structure of the Escherichia coli RNA polymerase alpha subunit amino-terminal domain. Science 1998, 281, 262–266. [Google Scholar] [CrossRef] [PubMed]
  8. Lara-Gonzalez, S.; Birktoft, J.J.; Lawson, C.L. Structure of the Escherichia coli RNA polymerase alpha subunit C-terminal domain. Acta Crystallogr. Sect. D Biol. Crystallogr. 2010, 66, 806–812. [Google Scholar] [CrossRef]
  9. Wada, T.; Yamazaki, T.; Kyogoku, Y. The structure and the characteristic DNA binding property of the C-terminal domain of the RNA polymerase alpha subunit from Thermus thermophilus. J. Biol. Chem. 2000, 275, 16057–16063. [Google Scholar] [CrossRef] [PubMed]
  10. Borin, B.N.; Tang, W.; Krezel, A.M. Helicobacter pylori RNA polymerase alpha-subunit C-terminal domain shows features unique to varepsilon-proteobacteria and binds NikR/DNA complexes. Protein Sci. 2014, 23, 454–463. [Google Scholar] [CrossRef] [PubMed]
  11. Opalka, N.; Brown, J.; Lane, W.J.; Twist, K.A.; Landick, R.; Asturias, F.J.; Darst, S.A. Complete structural model of Escherichia coli RNA polymerase from a hybrid approach. PLOS Biol. 2010, 8, e1000483. [Google Scholar] [CrossRef] [PubMed]
  12. Gulten, G.; Sacchettini, J.C. Structure of the MTB CarD/RNAP beta-lobes complex reveals the molecular basis of interaction and presents a distinct DNA-binding domain for MTB CarD. Structure 2013, 21, 1859–1869. [Google Scholar] [CrossRef] [PubMed]
  13. Chlenov, M.; Masuda, S.; Murakami, K.S.; Nikiforov, V.; Darst, S.A.; Mustaev, A. Structure and function of lineage-specific sequence insertions in the bacterial RNA polymerase beta' subunit. J. Mol. Biol. 2005, 353, 138–154. [Google Scholar] [CrossRef] [PubMed]
  14. Schwartz, E.C.; Shekhtman, A.; Dutta, K.; Pratt, M.R.; Cowburn, D.; Darst, S.; Muir, T.W. A full-length group 1 bacterial sigma factor adopts a compact structure incompatible with DNA binding. Chem. Biol. 2008, 15, 1091–1103. [Google Scholar] [CrossRef] [PubMed]
  15. Malhotra, A.; Severinova, E.; Darst, S.A. Crystal structure of a sigma70 subunit fragment from E. coli RNA polymerase. Cell 1996, 87, 127–136. [Google Scholar] [CrossRef] [PubMed]
  16. Campbell, E.A.; Muzzin, O.; Chlenov, M.; Sun, J.L.; Olson, C.A.; Weinman, O.; Trester-Zedlitz, M.L.; Darst, S.A. Structure of the bacterial RNA polymerase promoter specificity sigma subunit. Mol. Cell 2002, 9, 527–539. [Google Scholar] [CrossRef] [PubMed]
  17. Lambert, L.J.; Wei, Y.; Schirf, V.; Demeler, B.; Werner, M.H. T4 AsiA blocks DNA recognition by remodeling sigma70 region 4. EMBO J. 2004, 23, 2952–2962. [Google Scholar] [CrossRef]
  18. Feklistov, A.; Darst, S.A. Structural basis for promoter −10 element recognition by the bacterial RNA polymerase sigma subunit. Cell 2011, 147, 1257–1269. [Google Scholar] [CrossRef] [PubMed]
  19. Doucleff, M.; Pelton, J.G.; Lee, P.S.; Nixon, B.T.; Wemmer, D.E. Structural basis of DNA recognition by the alternative sigma-factor, sigma54. J. Mol. Biol. 2007, 369, 1070–1078. [Google Scholar] [CrossRef] [PubMed]
  20. Hong, E.; Doucleff, M.; Wemmer, D.E. Structure of the RNA polymerase core-binding domain of sigma54 reveals a likely conformational fracture point. J. Mol. Biol. 2009, 390, 70–82. [Google Scholar] [CrossRef] [PubMed]
  21. Doucleff, M.; Malak, L.T.; Pelton, J.G.; Wemmer, D.E. The C-terminal RpoN domain of sigma54 forms an unpredicted helix-turn-helix motif similar to domains of sigma70. J. Biol. Chem. 2005, 280, 41530–41536. [Google Scholar] [CrossRef] [PubMed]
  22. Lane, W.J.; Darst, S.A. The structural basis for promoter −35 element recognition by the group IV sigma factors. PLoS Biol. 2006, 4, e269. [Google Scholar] [CrossRef] [PubMed]
  23. Thakur, K.G.; Joshi, A.M.; Gopal, B. Structural and biophysical studies on two promoter recognition domains of the extra-cytoplasmic function sigma factor SigmaC from Mycobacterium tuberculosis. J. Biol. Chem. 2007, 282, 4711–4718. [Google Scholar] [CrossRef] [PubMed]
  24. Jaiswal, R.K.; Prabha, T.S.; Manjeera, G.; Gopal, B. Mycobacterium tuberculosis RsdA provides a conformational rationale for selective regulation of sigma-factor activity by proteolysis. Nucleic Acids Res. 2013, 41, 3414–3423. [Google Scholar] [CrossRef] [PubMed]
  25. Motackova, V.; Sanderova, H.; Zidek, L.; Novacek, J.; Padrta, P.; Svenkova, A.; Korelusova, J.; Jonak, J.; Krasny, L.; Sklenar, V. Solution structure of the N-terminal domain of Bacillus subtilis delta subunit of RNA polymerase and its classification based on structural homologs. Proteins 2010, 78, 1807–1810. [Google Scholar] [PubMed]
  26. Demo, G.; Papouskova, V.; Komarek, J.; Kaderavek, P.; Otrusinova, O.; Srb, P.; Rabatinova, A.; Krasny, L.; Zidek, L.; Sklenar, V.; et al. X-ray vs. NMR structure of N-terminal domain of delta-subunit of RNA polymerase. J. Struct. Biol. 2014, 187, 174–186. [Google Scholar] [CrossRef] [PubMed]
  27. Papouskova, V.; Kaderavek, P.; Otrusinova, O.; Rabatinova, A.; H, S.S.; Novacek, J.; Krasny, L.; Sklenar, V.; Zidek, L. Structural study of the partially disordered full-length delta subunit of RNA polymerase from Bacillus subtilis. Chembiochem 2013, 14, 1772–1779. [Google Scholar] [CrossRef] [PubMed]
  28. Keller, A.N.; Yang, X.; Wiedermannova, J.; Delumeau, O.; Krasny, L.; Lewis, P.J. Epsilon, a new subunit of RNA polymerase found in gram-positive bacteria. J. Bacteriol. 2014, 196, 3622–3632. [Google Scholar] [CrossRef] [PubMed]
  29. Zhang, G.; Campbell, E.A.; Minakhin, L.; Richter, C.; Severinov, K.; Darst, S.A. Crystal structure of Thermus aquaticus core RNA polymerase at 3.3 Å resolution. Cell 1999, 98, 811–824. [Google Scholar] [CrossRef] [PubMed]
  30. Minakhin, L.; Bhagat, S.; Brunning, A.; Campbell, E.A.; Darst, S.A.; Ebright, R.H.; Severinov, K. Bacterial RNA polymerase subunit omega and eukaryotic RNA polymerase subunit Rpb6 are sequence, structural, and functional homologs and promote RNA polymerase assembly. Proc. Natl. Acad. Sci. USA 2001, 98, 892–897. [Google Scholar] [CrossRef] [PubMed]
  31. Kuznedelov, K.; Lamour, V.; Patikoglou, G.; Chlenov, M.; Darst, S.A.; Severinov, K. Recombinant Thermus aquaticus RNA polymerase for structural studies. J. Mol. Biol. 2006, 359, 110–121. [Google Scholar] [CrossRef] [PubMed]
  32. Murakami, K.S.; Masuda, S.; Darst, S.A. Structural basis of transcription initiation: RNA polymerase holoenzyme at 4 Å resolution. Science 2002, 296, 1280–1284. [Google Scholar] [CrossRef] [PubMed]
  33. Vassylyev, D.G.; Sekine, S.; Laptenko, O.; Lee, J.; Vassylyeva, M.N.; Borukhov, S.; Yokoyama, S. Crystal structure of a bacterial RNA polymerase holoenzyme at 2.6 Å resolution. Nature 2002, 417, 712–719. [Google Scholar] [CrossRef] [PubMed]
  34. Tuske, S.; Sarafianos, S.G.; Wang, X.; Hudson, B.; Sineva, E.; Mukhopadhyay, J.; Birktoft, J.J.; Leroy, O.; Ismail, S.; Clark, A.D., Jr.; et al. Inhibition of bacterial RNA polymerase by streptolydigin: Stabilization of a straight-bridge-helix active-center conformation. Cell 2005, 122, 541–552. [Google Scholar] [CrossRef] [PubMed]
  35. Murakami, K.S. X-ray crystal structure of Escherichia coli RNA polymerase sigma70 holoenzyme. J. Biol. Chem. 2013, 288, 9126–9134. [Google Scholar] [CrossRef] [PubMed]
  36. Bae, B.; Davis, E.; Brown, D.; Campbell, E.A.; Wigneshweraraj, S.; Darst, S.A. Phage T7 gp2 inhibition of Escherichia coli RNA polymerase involves misappropriation of sigma70 domain 1.1. Proc. Natl. Acad. Sci. USA 2013, 110, 19772–19777. [Google Scholar] [CrossRef] [PubMed]
  37. Degen, D.; Feng, Y.; Zhang, Y.; Ebright, K.Y.; Ebright, Y.W.; Gigliotti, M.; Vahedian-Movahed, H.; Mandal, S.; Talaue, M.; Connell, N.; et al. Transcription inhibition by the depsipeptide antibiotic Salinamide A. eLife 2014, 3, e02451. [Google Scholar] [CrossRef] [PubMed]
  38. Murakami, K.S.; Masuda, S.; Campbell, E.A.; Muzzin, O.; Darst, S.A. Structural basis of transcription initiation: An RNA polymerase holoenzyme-DNA complex. Science 2002, 296, 1285–1290. [Google Scholar] [CrossRef] [PubMed]
  39. Zhang, Y.; Feng, Y.; Chatterjee, S.; Tuske, S.; Ho, M.X.; Arnold, E.; Ebright, R.H. Structural basis of transcription initiation. Science 2012, 338, 1076–1080. [Google Scholar] [CrossRef] [PubMed]
  40. Basu, R.S.; Warner, B.A.; Molodtsov, V.; Pupov, D.; Esyunina, D.; Fernandez-Tornero, C.; Kulbachinskiy, A.; Murakami, K.S. Structural basis of transcription initiation by bacterial RNA polymerase holoenzyme. J. Biol. Chem. 2014, 289, 24549–24559. [Google Scholar] [CrossRef] [PubMed]
  41. Zhang, Y.; Degen, D.; Ho, M.X.; Sineva, E.; Ebright, K.Y.; Ebright, Y.W.; Mekler, V.; Vahedian-Movahed, H.; Feng, Y.; Yin, R.; et al. GE23077 binds to the RNA polymerase “I” and “I+1” sites and prevents the binding of initiating nucleotides. eLife 2014, 3, e02450. [Google Scholar] [PubMed]
  42. Vassylyev, D.G.; Vassylyeva, M.N.; Zhang, J.; Palangat, M.; Artsimovitch, I.; Landick, R. Structural basis for substrate loading in bacterial RNA polymerase. Nature 2007, 448, 163–168. [Google Scholar] [CrossRef] [PubMed]
  43. Vassylyev, D.G.; Vassylyeva, M.N.; Perederina, A.; Tahirov, T.H.; Artsimovitch, I. Structural basis for transcription elongation by bacterial RNA polymerase. Nature 2007, 448, 157–162. [Google Scholar] [CrossRef] [PubMed]
  44. Weixlbaumer, A.; Leon, K.; Landick, R.; Darst, S.A. Structural basis of transcriptional pausing in bacteria. Cell 2013, 152, 431–441. [Google Scholar] [CrossRef] [PubMed]
  45. Sekine, S.; Murayama, Y.; Svetlov, V.; Nudler, E.; Yokoyama, S. The ratcheted and ratchetable structural states of RNA polymerase underlie multiple transcriptional functions. Mol. Cell 2015, 57, 408–421. [Google Scholar] [CrossRef] [PubMed]
  46. Cheetham, G.M.; Steitz, T.A. Structure of a transcribing T7 RNA polymerase initiation complex. Science 1999, 286, 2305–2309. [Google Scholar] [CrossRef] [PubMed]
  47. Steitz, T.A.; Steitz, J.A. A general two-metal-ion mechanism for catalytic RNA. Proc. Natl. Acad. Sci. USA 1993, 90, 6498–6502. [Google Scholar] [CrossRef] [PubMed]
  48. Fernandez-Tornero, C.; Moreno-Morcillo, M.; Rashid, U.J.; Taylor, N.M.; Ruiz, F.M.; Gruene, T.; Legrand, P.; Steuerwald, U.; Muller, C.W. Crystal structure of the 14-subunit RNA polymerase I. Nature 2013, 502, 644–649. [Google Scholar] [CrossRef] [PubMed]
  49. Engel, C.; Sainsbury, S.; Cheung, A.C.; Kostrewa, D.; Cramer, P. RNA polymerase I structure and transcription regulation. Nature 2013, 502, 650–655. [Google Scholar] [CrossRef] [PubMed]
  50. Cramer, P.; Bushnell, D.A.; Kornberg, R.D. Structural basis of transcription: RNA polymerase II at 2.8 Å resolution. Science 2001, 292, 1863–1876. [Google Scholar] [CrossRef] [PubMed]
  51. Hirata, A.; Klein, B.J.; Murakami, K.S. The X-ray crystal structure of RNA polymerase from archaea. Nature 2008, 451, 851–854. [Google Scholar] [CrossRef] [PubMed]
  52. Imashimizu, M.; Shimamoto, N.; Oshima, T.; Kashlev, M. Transcription elongation: Heterogeneous tracking of RNA polymerase and its biological implications. Transcription 2014, 5, e28285. [Google Scholar] [CrossRef] [PubMed]
  53. Liu, B.; Zuo, Y.; Steitz, T.A. Structural basis for transcription reactivation by RapA. Proc. Natl. Acad. Sci. USA 2015, 112, 2006–2010. [Google Scholar] [CrossRef] [PubMed]
  54. Sorenson, M.K.; Ray, S.S.; Darst, S.A. Crystal structure of the flagellar sigma/anti-sigma complex sigma28/flgm reveals an intact sigma factor in an inactive conformation. Mol. Cell 2004, 14, 127–138. [Google Scholar] [CrossRef] [PubMed]
  55. Campbell, E.A.; Greenwell, R.; Anthony, J.R.; Wang, S.; Lim, L.; Das, K.; Sofia, H.J.; Donohue, T.J.; Darst, S.A. A conserved structural module regulates transcriptional responses to diverse stress signals in bacteria. Mol. Cell 2007, 27, 793–805. [Google Scholar] [CrossRef] [PubMed]
  56. Campbell, E.A.; Tupy, J.L.; Gruber, T.M.; Wang, S.; Sharp, M.M.; Gross, C.A.; Darst, S.A. Crystal structure of Escherichia coli sigmaE with the cytoplasmic domain of its anti-sigma RseA. Mol. Cell 2003, 11, 1067–1078. [Google Scholar] [CrossRef] [PubMed]
  57. Shukla, J.; Gupta, R.; Thakur, K.G.; Gokhale, R.; Gopal, B. Structural basis for the redox sensitivity of the Mycobacterium tuberculosis SigK-RskA sigma-anti-sigma complex. Acta Crystallogr. Sect. D Biol. Crystallogr. 2014, 70, 1026–1036. [Google Scholar] [CrossRef]
  58. Campbell, E.A.; Masuda, S.; Sun, J.L.; Muzzin, O.; Olson, C.A.; Wang, S.; Darst, S.A. Crystal structure of the Bacillus stearothermophilus anti-sigma factor SpoIIAB with the sporulation sigma factor sigmaF. Cell 2002, 108, 795–807. [Google Scholar] [CrossRef] [PubMed]
  59. Patikoglou, G.A.; Westblade, L.F.; Campbell, E.A.; Lamour, V.; Lane, W.J.; Darst, S.A. Crystal structure of the Escherichia coli regulator of sigma70, Rsd, in complex with sigma70 domain 4. J. Mol. Biol. 2007, 372, 649–659. [Google Scholar] [CrossRef] [PubMed]
  60. Thakur, K.G.; Praveena, T.; Gopal, B. Structural and biochemical bases for the redox sensitivity of Mycobacterium tuberculosis RslA. J. Mol. Biol. 2010, 397, 1199–1208. [Google Scholar] [CrossRef] [PubMed]
  61. Benoff, B.; Yang, H.; Lawson, C.L.; Parkinson, G.; Liu, J.; Blatter, E.; Ebright, Y.W.; Berman, H.M.; Ebright, R.H. Structural basis of transcription activation: The CAP-alpha CTD-DNA complex. Science 2002, 297, 1562–1566. [Google Scholar] [CrossRef] [PubMed]
  62. Newberry, K.J.; Nakano, S.; Zuber, P.; Brennan, R.G. Crystal structure of the Bacillus subtilis anti-alpha, global transcriptional regulator, Spx, in complex with the alpha C-terminal domain of RNA polymerase. Proc. Natl. Acad. Sci. USA 2005, 102, 15839–15844. [Google Scholar] [CrossRef] [PubMed]
  63. Lamour, V.; Westblade, L.F.; Campbell, E.A.; Darst, S.A. Crystal structure of the in vivo-assembled Bacillus subtilis spx/RNA polymerase alpha subunit C-terminal domain complex. J. Struct. Biol. 2009, 168, 352–356. [Google Scholar] [CrossRef] [PubMed]
  64. Nakano, M.M.; Lin, A.; Zuber, C.S.; Newberry, K.J.; Brennan, R.G.; Zuber, P. Promoter recognition by a complex of Spx and the C-terminal domain of the RNA polymerase alpha subunit. PLOS ONE 2010, 5, e8664. [Google Scholar] [CrossRef] [PubMed]
  65. Westblade, L.F.; Campbell, E.A.; Pukhrambam, C.; Padovan, J.C.; Nickels, B.E.; Lamour, V.; Darst, S.A. Structural basis for the bacterial transcription-repair coupling factor/RNA polymerase interaction. Nucleic Acids Res. 2010, 38, 8357–8369. [Google Scholar] [CrossRef] [PubMed]
  66. Jain, D.; Nickels, B.E.; Sun, L.; Hochschild, A.; Darst, S.A. Structure of a ternary transcription activation complex. Mol. Cell 2004, 13, 45–53. [Google Scholar] [CrossRef] [PubMed]
  67. Blanco, A.G.; Canals, A.; Bernues, J.; Sola, M.; Coll, M. The structure of a transcription activation subcomplex reveals how sigma70 is recruited to PhoB promoters. EMBO J. 2011, 30, 3776–3785. [Google Scholar] [CrossRef] [PubMed]
  68. Hudson, B.P.; Quispe, J.; Lara-Gonzalez, S.; Kim, Y.; Berman, H.M.; Arnold, E.; Ebright, R.H.; Lawson, C.L. Three-dimensional EM structure of an intact activator-dependent transcription initiation complex. Proc. Natl. Acad. Sci. USA 2009, 106, 19830–19835. [Google Scholar] [CrossRef] [PubMed]
  69. Tagami, S.; Sekine, S.; Kumarevel, T.; Hino, N.; Murayama, Y.; Kamegamori, S.; Yamamoto, M.; Sakamoto, K.; Yokoyama, S. Crystal structure of bacterial RNA polymerase bound with a transcription inhibitor protein. Nature 2010, 468, 978–982. [Google Scholar] [CrossRef] [PubMed]
  70. James, E.; Liu, M.; Sheppard, C.; Mekler, V.; Camara, B.; Liu, B.; Simpson, P.; Cota, E.; Severinov, K.; Matthews, S.; et al. Structural and mechanistic basis for the inhibition of Escherichia coli RNA polymerase by T7 gp2. Mol. Cell 2012, 47, 755–766. [Google Scholar] [CrossRef] [PubMed]
  71. Twist, K.A.; Campbell, E.A.; Deighan, P.; Nechaev, S.; Jain, V.; Geiduschek, E.P.; Hochschild, A.; Darst, S.A. Crystal structure of the bacteriophage T4 late-transcription coactivator gp33 with the beta-subunit flap domain of Escherichia coli RNA polymerase. Proc. Natl. Acad. Sci. USA 2011, 108, 19961–19966. [Google Scholar] [CrossRef] [PubMed]
  72. Tagami, S.; Sekine, S.; Minakhin, L.; Esyunina, D.; Akasaka, R.; Shirouzu, M.; Kulbachinskiy, A.; Severinov, K.; Yokoyama, S. Structural basis for promoter specificity switching of RNA polymerase by a phage factor. Genes Dev. 2014, 28, 521–531. [Google Scholar] [CrossRef] [PubMed]
  73. Osmundson, J.; Montero-Diez, C.; Westblade, L.F.; Hochschild, A.; Darst, S.A. Promoter-specific transcription inhibition in Staphylococcus aureus by a phage protein. Cell 2012, 151, 1005–1016. [Google Scholar] [CrossRef] [PubMed]
  74. Mechold, U.; Potrykus, K.; Murphy, H.; Murakami, K.S.; Cashel, M. Differential regulation by ppgpp versus ppGpp in Escherichia coli. Nucleic Acids Res. 2013, 41, 6175–6189. [Google Scholar] [CrossRef] [PubMed]
  75. Zuo, Y.; Wang, Y.; Steitz, T.A. The mechanism of E. coli RNA polymerase regulation by ppGpp is suggested by the structure of their complex. Mol. Cell 2013, 50, 430–436. [Google Scholar] [CrossRef] [PubMed]
  76. Artsimovitch, I.; Patlan, V.; Sekine, S.; Vassylyeva, M.N.; Hosaka, T.; Ochi, K.; Yokoyama, S.; Vassylyev, D.G. Structural basis for transcription regulation by alarmone ppGpp. Cell 2004, 117, 299–310. [Google Scholar] [CrossRef] [PubMed]
  77. Vrentas, C.E.; Gaal, T.; Berkmen, M.B.; Rutherford, S.T.; Haugen, S.P.; Vassylyev, D.G.; Ross, W.; Gourse, R.L. Still looking for the magic spot: The crystallographically defined binding site for ppGpp on RNA polymerase is unlikely to be responsible for rRNA transcription regulation. J. Mol. Biol. 2008, 377, 551–564. [Google Scholar] [CrossRef] [PubMed]
  78. Jacob, F.; Monod, J. Genetic regulatory mechanisms in the synthesis of proteins. J. Mol. Biol. 1961, 3, 318–356. [Google Scholar] [CrossRef] [PubMed]
  79. Igarashi, K.; Ishihama, A. Bipartite functional map of the E. coli RNA polymerase alpha subunit: Involvement of the C-terminal region in transcription activation by cAMP-CRP. Cell 1991, 65, 1015–1022. [Google Scholar] [CrossRef] [PubMed]
  80. Campbell, E.A.; Korzheva, N.; Mustaev, A.; Murakami, K.; Nair, S.; Goldfarb, A.; Darst, S.A. Structural mechanism for rifampicin inhibition of bacterial RNA polymerase. Cell 2001, 104, 901–912. [Google Scholar] [CrossRef] [PubMed]
  81. Molodtsov, V.; Nawarathne, I.N.; Scharf, N.T.; Kirchhoff, P.D.; Showalter, H.D.; Garcia, G.A.; Murakami, K.S. X-ray crystal structures of the Escherichia coli RNA polymerase in complex with benzoxazinorifamycins. J. Med. Chem. 2013, 56, 4758–4763. [Google Scholar] [CrossRef] [PubMed]
  82. Campbell, E.A.; Pavlova, O.; Zenkin, N.; Leon, F.; Irschik, H.; Jansen, R.; Severinov, K.; Darst, S.A. Structural, functional, and genetic analysis of sorangicin inhibition of bacterial RNA polymerase. EMBO J. 2005, 24, 674–682. [Google Scholar] [CrossRef] [PubMed]
  83. Artsimovitch, I.; Vassylyeva, M.N.; Svetlov, D.; Svetlov, V.; Perederina, A.; Igarashi, N.; Matsugaki, N.; Wakatsuki, S.; Tahirov, T.H.; Vassylyev, D.G. Allosteric modulation of the RNA polymerase catalytic reaction is an essential component of transcription control by rifamycins. Cell 2005, 122, 351–363. [Google Scholar] [CrossRef] [PubMed]
  84. Temiakov, D.; Zenkin, N.; Vassylyeva, M.N.; Perederina, A.; Tahirov, T.H.; Kashkina, E.; Savkina, M.; Zorov, S.; Nikiforov, V.; Igarashi, N.; et al. Structural basis of transcription inhibition by antibiotic streptolydigin. Mol. Cell 2005, 19, 655–666. [Google Scholar] [CrossRef] [PubMed]
  85. Mukhopadhyay, J.; Das, K.; Ismail, S.; Koppstein, D.; Jang, M.; Hudson, B.; Sarafianos, S.; Tuske, S.; Patel, J.; Jansen, R.; et al. The RNA polymerase “switch region” is a target for inhibitors. Cell 2008, 135, 295–307. [Google Scholar] [CrossRef] [PubMed]
  86. Belogurov, G.A.; Vassylyeva, M.N.; Sevostyanova, A.; Appleman, J.R.; Xiang, A.X.; Lira, R.; Webber, S.E.; Klyuyev, S.; Nudler, E.; Artsimovitch, I.; et al. Transcription inactivation through local refolding of the RNA polymerase structure. Nature 2009, 457, 332–335. [Google Scholar] [CrossRef] [PubMed]
  87. Molodtsov, V.; Fleming, P.R.; Eyermann, C.J.; Ferguson, A.D.; Foulk, M.A.; McKinney, D.C.; Masse, C.E.; Buurman, E.T.; Murakami, K.S. X-ray crystal structures of Escherichia coli RNA polymerase with switch region binding inhibitors enable rational design of squaramides with an improved fraction unbound to human plasma protein. J. Med. Chem. 2015, 58, 3156–3171. [Google Scholar] [CrossRef] [PubMed]
  88. Buurman, E.T.; Foulk, M.A.; Gao, N.; Laganas, V.A.; McKinney, D.C.; Moustakas, D.T.; Rose, J.A.; Shapiro, A.B.; Fleming, P.R. Novel rapidly diversifiable antimicrobial RNA polymerase switch region inhibitors with confirmed mode of action in Haemophilus influenzae. J. Bacteriol. 2012, 194, 5504–5512. [Google Scholar] [CrossRef] [PubMed]

Share and Cite

MDPI and ACS Style

Murakami, K.S. Structural Biology of Bacterial RNA Polymerase. Biomolecules 2015, 5, 848-864. https://doi.org/10.3390/biom5020848

AMA Style

Murakami KS. Structural Biology of Bacterial RNA Polymerase. Biomolecules. 2015; 5(2):848-864. https://doi.org/10.3390/biom5020848

Chicago/Turabian Style

Murakami, Katsuhiko S. 2015. "Structural Biology of Bacterial RNA Polymerase" Biomolecules 5, no. 2: 848-864. https://doi.org/10.3390/biom5020848

Article Metrics

Back to TopTop